Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY
Clinical observational studies using epidemiologic theories and methods. Through the collection of various clinically relevant data, specific outcomes are evaluated in hematologic transplant patients, providing high quality real-world data for clinical practice, informing public health decision-making, and reducing the burden of disease
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• At least one visit to a stem cell transplant center beginning January 1, 2021
• Proposed to undergo or have undergone hematopoietic stem cell transplantation
Locations
Other Locations
China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITING
Shanghai
Shanghai Liquan Hospital
NOT_YET_RECRUITING
Shanghai
Shanghai Zhaxin Hospital
NOT_YET_RECRUITING
Shanghai
Contact Information
Primary
Xiaoxia Hu
hu_xiaoxia@126.com
(86) 13795437259
Backup
Xiaoxia HU
hu_xiaoxia@126.com
02164370045
Time Frame
Start Date: 2021-05-01
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 3000
Treatments
Cohort 1
Patients who are proposed to undergo or have undergone allogeneic hematopoietic stem cell transplantation at the Stem Cell Transplant Center and Post-Transplant Medical Consortium at Regent Hospital
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital